Bioactivity:

LY2922470 reduces glucose levels along with significant enhancements in insulin and GLP-1, which is the potential for the treatment of type 2 diabetes mellitus (T2DM). LY2922470 is an effective, selective, and orally available agonist of the G protein-cou

CAS nr:

1423018-12-5

Purity:

98%

Molecular Weight:

475,6

SMILES:

COC1=C(N(CC2=CC=C(COC3=CC=C([C@@H](C#CC)CC(O)=O)C=C3)S2)CCC4)C4=CC=C1

Formula:

C28H29NO4S

Pathway:

Endocrinology/Hormones,GPCR/G Protein

Target:

GPR,GPR